Investment analysts at StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.
NantHealth Trading Down 46.6 %
Shares of NantHealth stock opened at $1.35 on Wednesday. The company has a 50 day moving average of $2.06 and a 200-day moving average of $2.24. The company has a market cap of $10.40 million, a PE ratio of -0.18 and a beta of 1.82. NantHealth has a 1-year low of $1.24 and a 1-year high of $9.75.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Susquehanna International Group LLP bought a new position in shares of NantHealth in the first quarter valued at approximately $25,000. Goldman Sachs Group Inc. purchased a new position in shares of NantHealth during the 2nd quarter valued at about $36,000. Atria Wealth Solutions Inc. bought a new stake in NantHealth in the 1st quarter worth approximately $170,000. Finally, Millennium Management LLC bought a new position in NantHealth during the second quarter valued at approximately $110,000. Institutional investors own 4.50% of the company’s stock.
NantHealth Company Profile
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.